Do you want to read an article? Please log in or register.
Closed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel-group trial.
Diabetes - GeneralType 2 Diabetes
Related content
COMMENTED
Type 1 Diabetes
Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial
Lancet.
Tauschmann M, Thabit H, Bally L, Allen JM, Hartnell S, Wilinska ME, Ruan Y, Sibayan J, Kollman C, Cheng P, Beck RW, Acerini CL, Evans ML, Dunger DB, Elleri D, Campbell F, Bergenstal RM, Criego A, Shah VN, Leelarathna L, Hovorka R; APCam Consortium
doi: 10.1016/S0140-6736(18)31947-0.
Diabetes - GeneralType 1 DiabetesGlycemic Control
Day-and-Night Closed-Loop Insulin Delivery in a Broad Population of Pregnant Women With Type 1 Diabetes: A Randomized Controlled Crossover Trial
Diabetes Care.
Stewart ZA, Wilinska ME, Hartnell S, O'Neil LK, Rayman G, Scott EM, Barnard K, Farrington C, Hovorka R, Murphy HR
doi: 10.2337/dc17-2534.
COMMENTED
Glycemic Control
Fully closed-loop insulin delivery in inpatients receiving nutritional support: a two-centre, open-label, randomised controlled trial
Lancet Diabetes Endocrinol.
Boughton CK, Bally L, Martignoni F, Hartnell S, Herzig D, Vogt A, Wertli MM, Wilinska ME, Evans ML, Coll AP, Stettler C, Hovorka R
doi: 10.1016/S2213-8587(19)30061-0.
COMMENTED
Type 1 Diabetes
Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
★ 2
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
N Engl J Med.
Brown SA, Kovatchev BP, Raghinaru D, Lum JW, Buckingham BA, Kudva YC, Laffel LM, Levy CJ, Pinsker JE, Wadwa RP, Dassau E, Doyle FJ 3rd, Anderson SM, Church MM, Dadlani V, Ekhlaspour L, Forlenza GP, Isganaitis E, Lam DW, Kollman C, Beck RW, iDCL Trial Research Group.
doi: 10.1056/NEJMoa1907863.
Diabetes - GeneralType 1 Diabetes
Hypoglycaemia Incidence and Recovery During Home Use of Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes
Diabetes Obes Metab.
Ruan Y, Bally L, Thabit H, Leelarathna L, Hartnell S, Tauschmann M, Wilinska ME, Evans ML, Mader JK, Kojzar H, Dellweg S, Benesch C, Arnolds S, Pieber TR, Hovorka R
doi: 10.1111/dom.13304.
COMMENTED
Diabetes - General
Medicines for Treatment Intensification in Type 2 Diabetes and Type of Insulin in Type 1 and Type 2 Diabetes in Low-Resource Settings: Synopsis of the World Health Organization Guidelines on Second- and Third-Line Medicines and Type of Insulin for the Control of Blood Glucose Levels in Nonpregnant Adults With Diabetes Mellitus
Ann Intern Med.
Roglic G, Norris SL
doi: 10.7326/M18-1149.
Diabetes - GeneralType 1 Diabetes
Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open-label, randomised, crossover study.
Lancet Diabetes Endocrinol.
Bally L, Thabit H, Kojzar H, Mader JK, Qerimi-Hyseni J, Hartnell S, Tauschmann M, Allen JM, Wilinska ME, Pieber TR, Evans ML, Hovorka R
doi: 10.1016/
Type 2 DiabetesGlycemic Control
Effect of fully automated closed-loop insulin delivery using faster aspart versus standard aspart on gluco-regulatory hormones in type 2 diabetes
Diabetes Obes Metab.
Herzig D, Studer D, Nakas CT, Kuenzli C, Stauffer TP, Hovorka R, Bally L
doi: 10.1111/dom.14185.
COMMENTED
Type 1 Diabetes
A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes
★ 2
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
N Engl J Med
Breton MD, Kanapka LG, Beck RW, Ekhlaspour L, Forlenza GP, Cengiz E, Schoelwer M, Ruedy KJ, Jost E, Carria L, Emory E, Hsu LJ, Oliveri M, Kollman CC, Dokken BB, Weinzimer SA, DeBoer MD, Buckingham BA, Cherñavvsky D, Wadwa RP, iDCL Trial Research Group.
doi: 10.1056/NEJMoa2004736